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THE ROLE OF THE ENDOTHELIUM IN ATTENUATION OF SYMPATHETIC 
ADRENERGIC VASOCONSTRICTION 
KRUTI PATEL 
ABSTRACT 
 The cardiovascular system helps maintain blood pressure and blood flow to the 
different organ systems through many elaborate mechanisms. These mechanisms include 
the different blood vessels, each with their own properties, as well as both neural and 
humoral factors. The vessels that are most relevant here are arterioles, also known as 
resistance vessels, as they play a significant role in regulating organ blood flow, vascular 
resistance, and blood pressure in many different physiological conditions, such as 
exercise. More specifically, the focus of this paper is the endothelial layer of the arteriolar 
wall and its role in attenuating sympathetic adrenergic vasoconstriction, or 
sympatholysis. 
 Exercising skeletal muscle cells require an increase in blood flow to adequately 
meet their oxygen and nutrient demands. In order to accomplish this, there is an increase 
in cardiac output by the heart and also a redistribution of blood flow away from inactive 
regions towards active muscle cells. This critical redistribution of blood flow depends on 
the sympathetic nervous system, which increases in activity during contraction to cause 
vasoconstriction of the arterioles that supply other inactive organs except the brain. 
Despite this increase in sympathetic nerve activity, there is also profound vasodilation in 
the microvasculature of active skeletal muscle cells. It is this paradox that helps match 
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the increase in metabolism with an increase in blood flow during exercise, and it is also 
this mechanism that has been coined ‘functional sympatholysis.’ 
 Although much effort has been put into studying the mechanism through which 
functional sympatholysis occurs, the existing data and evidence are not sufficient to 
deduce a clear picture at this time. There are inconsistencies regarding the functional 
distribution of alpha-adrenergic receptors, the role of non-adrenergic receptors, the 
impact of many different metabolic factors, and finally also the contribution of non-
metabolic factors. Due to such contrasting data, it is clear that further research will need 
to be conducted in order to obtain a concrete explanation for sympatholysis. 
 A recent study has postulated that the process of sympatholysis may primarily 
involve the endothelium. This study used various manipulations that involved 
endothelium-dependent vasodilatory responses as well as endothelium-independent 
vasodilatory responses intersected with sympathetic adrenergic nerve activity to 
determine that only those vasodilatory agents that functioned using the endothelium were 
able to attenuate sympathetic adrenergic vasoconstriction. This compelling evidence has 
made way for further inquiry into the endothelium’s role in this very important process. 
 Due to the fact that the greatest amount of research has been devoted to studying 
the contraction-related attenuated responsiveness of alpha-adrenergic receptors, a 
hypothetical study and its various methods are proposed in this paper. This hypothesis 
states that both adenosine triphosphate and flow-mediated dilation, two vasodilatory 
stimuli that rely on a functional endothelium, are sympatholytic agents, whereas 
adenosine, which acts on vascular smooth muscle to cause vasodilation, is not 
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sympatholytic. The conclusions that might be drawn from such a study and their various 
implications are also discussed. 
 Finally, the major relevancy in this topic relates to the fact that sympatholysis or 
impaired sympatholysis may be a factor in many metabolic and cardiovascular diseases 
along with exercise. Some of the diseases discussed here are type II diabetes, 
hypertension, and chronic myocardial infarction. A concrete understanding of the 
mechanism by which this process occurs would potentially help invent new treatment 
plans and prevention. At this point, it seems probable that the endothelium does play a 
significant role in sympatholysis, but whether it is the primary dictator and whether there 
are also other influences that are absolutely essential still remains relatively uncertain.  
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INTRODUCTION 
Background 
The cardiovascular system includes blood and all of its components, the heart, 
which is responsible for pumping of the blood, all of the vessels that transport the blood 
to and from the different tissues, and an extensive capillary system, which functions as 
the site of nutrient and waste exchange. This system is additionally composed of neural 
and humoral components and functions mainly to deliver oxygen and nutrients to the 
various organ systems and remove their waste products. In order to regulate tissue 
oxygen and nutrient supply, the circulatory system modulates blood pressure, body 
temperature, blood volume, and heart performance. 
The numerous blood vessels that carry all the blood vary not only in size and 
appearance but also in the characteristics of the blood that they transport. Although there 
are a few important exceptions, such as the pulmonary arteries and pulmonary veins, the 
vast majority of arteries and arterioles carry oxygenated blood away from the heart and 
towards the tissues, whereas veins and venules carry deoxygenated blood back to the 
heart. The important nutrient and waste exchange that takes place between the blood and 
tissues happens within the capillaries. Moreover, the Starling forces govern this important 
exchange by equating that any fluid movement across capillary membranes is dependent 
on the hydrostatic pressure gradient and the oncotic pressure gradient across the capillary. 
Even though capillary walls are leaky and porous allowing diffusion to take place, the 
fluid movement across a capillary bed is due to filtration from a region of high pressure 
to a region of low pressure (Fox et al., 1993). These fundamental laws also take into 
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consideration other factors such as capillary permeability and the type of capillary bed in 
question. 
 Although there are physical similarities between the types of blood vessels, there 
are also some important differences. Both arteries and veins are made up of three 
different vessel layers, each with its own characteristics. They contain an outer adventitial 
layer, a middle smooth muscle layer, and an inner endothelial cell layer (Figure 1). 
However, arteries not only appear red in color unlike veins, which have a blue 
appearance, but they are also thicker walled (Klabunde, 2011). Arteries have a thicker 
smooth muscle layer because they experience a greater pressure than veins. Capillaries, in 
contrast, are made up of a single layer of endothelial cells (EC). This allows for efficient 
nutrient and metabolite exchange, as capillaries are extensive in both volume and surface 
area. In skeletal muscle alone, the capillary surface area is estimated to be around 7 m2 
kg-1 of the entire muscle, thus allowing this organ system to have a great capacity to 
exchange oxygen and metabolites between the blood and cells (Nixon, 1988). Since 
capillaries are close in proximity to the tissues and have very thin walls, there is a short 
diffusion distance that permits gases to move across relatively quickly (Fox et al., 1993). 
Furthermore, they are extensively branched and have very small diameters, augmenting 
their ability to thoroughly oxygenate all tissues. 
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Figure 1: A comparison of arteries, veins, and capillaries.  The walls of arteries and 
veins consist of three different layers, although they differ in proportion. The outer adventitia is 
made up of collagen fibers, the middle muscle layer is made up of smooth muscle and elastic 
fibers, and the inner endothelium is a single layer of cells that line the lumen. Capillary walls 
contain only a single layer of endothelial cells. Image taken from 
https://en.wikipedia.org/wiki/Blood_vessel. 03/04/17. 
Arterioles are known as resistance vessels because they experience the greatest 
drop in pressure in the cardiovascular system due to the fact that they are the sites of 
greatest reduction in total cross-sectional area for blood flow. They play an essential role 
in controlling local organ blood flow, vascular resistance, and arterial blood pressure. 
Since blood pressure is dependent on cardiac output and total peripheral resistance, 
alterations in one or both of these can maintain blood pressure at appropriate levels. The 
manner in which arterioles regulate the amount of blood that perfuses the different organ 
capillaries is dependent on multiple mechanisms, which include autoregulation, neural 
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and humoral components, and also the endothelium (Nixon, 1988). Arterioles can be 
stimulated by the autonomic nervous system in various ways to alter their tone and 
influence both pressure and perfusion. Additionally, Poiseuille’s Law, which explains 
blood flow through any vessel in a steady state (blood flow= ΔPπr4/8ηl, where ΔP is the 
pressure gradient across the vessel, r is the vessel radius, η is the viscosity, and l is the 
vessel length), illustrates that any small change in vascular diameter results in a large 
change in blood flow, due to a change in resistance that is proportional to 1/r4. 
Autoregulation 
 Tonic vasoconstriction in arterioles is crucial for survival because without it, 
arterioles would be maximally dilated, and this would outstrip the capability of cardiac 
output to maintain constant arterial blood pressure (Nixon, 1988). Conservation of this 
basal vasoconstrictor tone is an intrinsic property of arteriolar smooth muscle, which 
occurs independent of metabolite, neural, or humoral inputs. This basal myogenic tone 
can be modulated by both neural and humoral factors, leading to either an increase or 
decrease in arteriolar tone. 
 The myogenic response keeps blood flow through an organ constant by altering 
vessel resistance in the face of moment-to-moment fluctuations in arterial blood pressure 
(Figure 2). When blood pressure rises, arteriolar smooth muscle contracts, increasing 
resistance and reducing blood flow to downstream tissues. The converse is also true. In 
this regard, the smooth muscle, which is the primary dictator of the myogenic response, 
acts as a mechanical sensor that senses the change in pressure and adjusts its resistance 
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appropriately to retain an appropriate tissue blood flow and perfusion pressure (Nixon, 
1988). 
  
 
Figure 2: The autoregulatory response. ( + ), starting blood flow and pressure; (ο), 
immediate change in flow after the pressure change; (), stable flow values reached 1-3mins after 
sustained pressure change. Figure adapted from Intrinsic Regulation of Skeletal Muscle Blood 
Flow, (Jones & Berne, 1964). 
 
 
The alternative hypothesis of autoregulation deals with blood flow and the 
concentration of vasoactive metabolites within the different tissues. This mechanism 
involves vascular smooth muscle acting like a mechanosensor rather than a chemosensor. 
In this regard, a decrease in blood flow results in a buildup of vasoactive metabolites, 
which then leak out into the interstitial space to cause vasodilation. If instead there is an 
increase in blood flow, these vasoactive metabolites get washed away leading to 
vasoconstriction. Since blood flow is significantly linked to metabolism in many different 
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vascular beds, such as skeletal muscle, this underlying mechanism of autoregulation 
appears to hold some value (Nixon, 1988). 
 Neural and humoral factors extrinsically influence basal tone by adding to it as 
vasoconstrictors or by subtracting from it as vasodilators. Since the degree of basal tone 
and resting sympathetic tone differs among organs, neural and humoral stimuli can have 
various effects on vessel tone among different organ systems. Sympathetic outflow can 
either cause vasoconstriction, if say norepinephrine is released from nerve terminals to 
bind its adrenergic receptors, or vasodilation if acetylcholine is released to bind 
cholinergic receptors. With respect to humoral control, many circulating hormones that 
are released through homeostatic reflexes and also those that are released in response to 
injury can contribute to changes in vessel tone to alter blood pressure or blood volume 
since a change in blood volume directly correlates with a change in blood pressure. 
Depending on the organ involved and homeostatic state, these hormones have different 
effects on different tissues. A few known examples of hormones that are vasoconstrictors 
are angiotensin II and vasopressin, while vasodilators include bradykinin, histamine, and 
also prostaglandins (Nixon, 1988). 
Endothelium  
EC’s define the inner lining of the entire cardiovascular system and are 
advantageously located between the blood and blood vessel wall, allowing them to have 
direct contact and communication with both elements. Since blood vessels are subject to 
various types of mechanical forces, such as stretch, shear stress, and blood flow, they 
must be equipped with the appropriate mechanisms to maintain basal levels of these same 
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mechanical stresses (Lehoux et al., 2006). ECs respond to changes in and are a part of 
important mechanisms that modify vessel diameter, vessel tone, and vessel composition 
to retain basal levels of stretch and therefore blood pressure. These mechanisms mainly 
involve the release of many different vasoactive compounds by the endothelium as well 
as the expression of different receptors located on the endothelium via different agonists, 
such as ACh. 
 ECs have the ability to produce and release a number of substances in response to 
external stimuli, the activation of intrinsic compounds, and mechanical stress. Some of 
these include nitric oxide (NO), adenosine (Ado), potassium (K+), adenosine triphosphate 
(ATP), eicosatrienoic acids (EETs), endothelium-derived hyperpolarizing factors 
(EDHFs) and prostaglandins (PGs) (See Figure 4). A few of these vasodilators can also 
be released by skeletal muscle cells, red blood cells, and nerve terminals as a 
consequence of similar stimuli (Clifford & Hellsten, 2004). Since these agents are 
released in response to mechanical change, it makes sense that these vasoactive 
compounds are likely elevated in conditions like exercise and disease, bearing the 
responsibility for the different vascular changes observed in these states. This is also 
discussed later more in detail. 
 NO is a freely diffusible gas that is continuously formed by the arterial 
endothelium. Its production in arterial endothelial cells is stimulated by shear stress to 
cause flow-induced vasodilation and also by inflammatory substances to cause 
inflammatory vasodilation. Vascular ECs are one place where the enzyme nitric oxide 
synthase (eNOS) is found, making them one source of NO. Located on the endothelial 
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cell membrane, eNOS catalyzes the formation of NO by cleaving the nitrogen group on 
the amino acid L-arginine and combining it with oxygen. NO’s release from the 
endothelium can also be enhanced by other molecules, such as acetylcholine, bradykinin, 
and ATP binding their own receptors on the vascular endothelium (Furchgott & Martin, 
1985). Red blood cells, along with releasing ATP, might also play a role in releasing NO 
through higher deoxygenated hemoglobin levels (Mortensen et al., 2009). According to 
one study, NO has the potential to bind the hemoglobin molecule and be released from it 
due to the off-loading of oxygen (Stamler et al., 1997). NO helps regulate the basal 
vascular tone in many different tissues and its main vasodilatory effects involve 
hyperpolarization of vascular smooth muscle cells. There is also reason to believe that 
NO can cause the endothelium to release vasodilating PGs to mediate vascular relaxation 
(Vassalle et al., 2003). 
 Cyclooxygenase (COX) is an enzyme that catalyzes the production of 
prostaglandin E2, prostacyclin, and thromboxane A2 from arachidonic acid. Among these, 
prostaglandin and prostacyclin are vasodilators whereas thromboxane A2 is a 
vasoconstrictor. Both vascular endothelial cells and skeletal muscle cells are sources of 
these vasoactive prostanoids (Vandenburgh et al., 1990). Prostanoids are ubiquitously 
produced in almost all types of cells, and they function to maintain renal function, body 
fluid homeostasis, and blood pressure in the body during times of inflammation. After 
they are formed, they bind to receptors on vascular smooth muscle cells to decrease 
intracellular calcium (Ca2+) levels and promote vascular relaxation. The exact role of 
prostanoids in exercise hyperemia, however, is still unclear. 
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 Finally, a whole class of EDHFs may also contribute to endothelium-dependent 
relaxation, thus making them another determinant of a healthy endothelium. The 
vasodilatory effect of EDHFs depends on the increase in endothelial Ca2+ levels, 
subsequent hyperpolarization of the endothelium due to activation of calcium-dependent 
potassium channels, and a transfer of that hyperpolarization over to smooth muscle cells 
(Busse et al., 2002). Research has shown that when other endothelium-dependent 
vasodilators are limited in number or as the vessel size decreases, EDHF levels increase 
in arterioles to compensate for the change (Clifford & Hellsten, 2004). In this way, 
EDHFs can regulate organ blood flow, peripheral vascular resistance, and blood pressure. 
Although EDHFs are found and vary in many different types of tissues depending on the 
enzymes available and vessel size in question, and potassium (K+) has been linked to 
endothelium-dependent vasodilation in rodent arteries (De Clerck et al., 2003), further 
studies will need to be executed to determine EDHFs’ direct involvement in exercise 
hyperemia. 
In regards to the vascular endothelium, ATP is another important factor that 
deserves attention. There are P2Y purinergic G protein-coupled receptors located on 
vascular ECs that bind ATP and cause a release of vasodilators such as NO, EDHFs, and 
PGs. The potential sources of ATP may be the endothelium itself, the local circulation, 
the muscle interstitium, or red blood cells in response to mechanical deformation and 
increased levels of deoxygenated hemoglobin (Clifford & Hellsten, 2004; Ellsworth et 
al., 2009). In fact, recent investigations have shown that ATP release by erythrocytes is 
directly linked to hemoglobin saturation levels in a number of different species (Jagger et 
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al., 2001). These studies imply that if ATP is released by red blood cells due to such a 
physiological stimulus, the ATP must cause profound vasodilation to increase vascular 
perfusion. Even though many believe that ATP levels increase during exercise, the 
definite relationship between ATP and exercise hyperemia is still poorly understood. 
 
Figure 3: Vasodilating compounds formed by the endothelium in skeletal muscle 
tissue. As a response to stimuli from other compounds or from shear stress, EC’s can form NO, 
EDHF, EET’s, PG’s, and Ado. Figure reproduced from Vasodilatory mechanisms in contracting 
skeletal muscle, (Clifford & Hellsten, 2004). 
 
Flow-Mediated Dilation 
 The concept of flow-mediated dilation (FMD) was discovered some fifty years 
ago, and it describes the vasodilatory response of a blood vessel to an elevation in blood 
flow. It primarily represents the endothelial response to shear stress through the release of 
certain vasoactive substances, such as NO, PGI2, and EDHF (Pohl et al., 1986). Although 
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it was previously believed that both peripheral and local mechanisms were responsible in 
eliciting the vasodilation, it has been validated to be endothelium-dependent through 
former studies that have shown that damaging the endothelium abolishes this response 
(Pohl et al., 1986). 
 Several different mechanisms are involved in FMD, and these different methods 
are highly sensitive to the nature of the stimulus present (Pyke & Tschakovsky, 2005). It 
is generally believed that increased shear stress due to increased blood flow produces an 
endothelial derived, NO-mediated vasodilation. However, various other vasoactive 
substances, such as PGI2 and EDHF, are also released by the endothelium under shear 
stress. This is important in distinguishing that not all FMD is NO-mediated, and it still 
remains relatively unclear which of these other players serves a significant role in making 
FMD an endothelial process (Pyke & Tschakovsky, 2005). 
 It has been demonstrated that the dilation to flow can be both tissue specific and 
fiber specific. One study done with the human radial artery showed that blocking NO 
production with a nitric oxide synthase inhibitor abolished the dilatory response, 
indicating NO-dependence (Mullen et al., 2001). Prolongation of this blocking, however, 
proved to be independent of both NO and PGs by exhibiting a vasodilatory response to 
flow, which is somewhat contradictory. Another study performed with the rat soleus 
muscle and gastrocnemius muscle arterioles revealed contrasting results with a link to K+ 
channel activation and no indication of NO-dependence on the initial vasodilatory 
response to flow except in the case of sustained flow. In fact, the onset and maintenance 
of FMD was faster and greater in the gastrocnemius muscle than the soleus muscle 
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(Shipley et al., 2005). Since different skeletal muscle fiber types demonstrate different 
patterns of blood flow, it was reasonable to investigate flow-induced vasodilation in 
soleus muscle, which is comprised of mainly slow-twitch fibers, and in gastrocnemius 
muscle, which is composed of mainly fast-twitch fibers. As can be seen from the study by 
Shipley et al., the specific mechanisms that provide the onset and sustainment of flow-
mediated dilation with different stimuli and in different muscle tissue types are 
heterogeneous. It is certain, however, that this process occurs by means of local 
mechanisms, implicating an important role for the endothelium. 
Vascular Smooth Muscle 
 Surrounding the inner endothelial cell layer of the vasculature is a thicker layer of 
smooth muscle. Unlike the heart, which undergoes continuous muscle contractions that 
are rapid and short in duration, the contractions of vascular smooth muscle cells are slow 
and tonic. Even though they do not contain the same proteins and arrangement as skeletal 
and cardiac muscle cells, smooth muscle cells are appropriately built to manage both 
vascular tone and luminal diameter (Figure 4). 
 
Figure 4. A smooth muscle cell in the relaxed and contracted state. Image taken from 
https://commons.wikimedia.org/wiki/File:1028_Smooth_Muscle_Contraction.jpg. 03/20/17. 
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 There are a number of different mechanical, electrical, and chemical stimuli that 
can trigger a response from vascular smooth muscle cells. As discussed earlier, slight 
stretching of vascular smooth muscle can cause it to contract in what is known as the 
myogenic response. Additionally, electrical depolarization of the smooth muscle cell 
membrane can lead to the opening of voltage-gated calcium channels, an increase in 
intracellular Ca2+ levels, and subsequent contraction. Finally, a number of chemical 
stimuli, some of which include norepinephrine, angiotensin II, endothelin-1, and 
vasopressin, bind to receptors located on vascular smooth muscle cells to mediate 
contraction through various signal transduction pathways (Klabunde, 2011). 
 Just like skeletal muscle, an increase in intracellular Ca2+ levels is crucial for 
smooth muscle contraction. The influx of Ca2+ can result from stimulation of calcium 
channels, the release by intracellular stores such as the sarcoplasmic reticulum (SR), or 
both, as is the case for smooth muscle. The Ca2+ then binds a calcium-binding protein 
called calmodulin, which leads to the activation of myosin light chain kinase (MLCK), an 
enzyme that phosphorylates myosin light chains (MLCs) on myosin heads in the presence 
of ATP. These processes lead to the formation and cycling of cross-bridges between 
myosin heads and actin filaments to cause smooth muscle contraction. On the other hand, 
vascular smooth muscle relaxes if there is reduced phosphorylation of MLC, which can 
result from decreased Ca2+ entry, inhibition of MLCK by increases in cAMP, or MLC 
dephosphorylation (Klabunde, 2011). 
 Vascular smooth muscle contractile tone and MLC phosphorylation are dependent 
on the activation of different G-protein coupled receptors as well as nitric oxide 
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activation of guanylyl cyclase and cGMP formation. For example, norepinephrine, 
angiotensin II, endothelin-1, and vasopressin cause Gq protein activation leading to 
increased Ca2+ levels and prevention of MLC dephosphorylation. Norepinephrine can 
also activate Gi proteins to reduce cAMP levels and increase MLCK activity, eliciting 
contraction of vascular smooth muscle. Other chemicals like epinephrine, adenosine, and 
prostacyclin cause Gs protein activation and increased cAMP levels, producing inhibition 
of MLCK, and promotion of smooth muscle relaxation (Klabunde, 2011) (Figure 5). This 
information makes it evident that Ca2+ is a crucial component in muscular contraction 
and that different chemicals and signal transduction pathways are involved to either cause 
smooth muscle contraction or relaxation. These properties, however, are imperative in 
aiding vascular smooth muscle to alter vessel diameter and regulate vascular tonic 
changes. 
 
Figure 5. Vascular smooth muscle contraction. Image adopted from Cardiovascular 
Physiology Concepts, (Klabunde, 2011). 
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Adventitia 
 Finally, the outermost layer of the vascular wall consists of an adventitia, a layer 
that is essentially connective tissue (Figure 6). Even though it is often overlooked, the 
adventitial layer is very complex and heterogeneous, containing structures such as 
fibroblasts, blood vessels, nerves, and also immune cells (Stenmark et al., 2013). 
Adventitial cells are capable of both sensing injurious changes as well as making the 
appropriate adjustments using their own machinery and the cells of the neighboring 
tissues. An accumulating amount of research is also now beginning to confirm that the 
adventitia is dynamically involved in cell trafficking into and out of the vessel wall and 
also in communication between the vascular endothelial cells, smooth muscle cells, and 
the local environment. In this sense, along with vascular smooth muscle cells and 
endothelial cells, the adventitia may also play an important role in influencing vascular 
tone. 
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Figure 6. Adventitial layer of the vessel wall. Image taken from 
https://commons.wikimedia.org/wiki/File:Endotelijalna_%C4%87elija.jpg. 03/20/17. 
Exercise Physiology 
In order to adequately meet the metabolic demands of exercise, there needs to be 
not only an increase in cardiac output by the heart but also a redistribution of blood flow 
away from inactive organs to the working skeletal muscle cells. In fact, exercise can 
increase the cardiac output from 5-6 liters of blood flow per minute to five times that 
value and increase blood flow to working muscles by almost 70% (Chapman et al., 
1967).This fundamental reallocation of blood flow is largely mediated by the autonomic 
nervous system, specifically the sympathetic branch. 
At rest, only 20 percent of the body’s total oxygen consumption, or about 70 
milliliters of oxygen per minute, is utilized by muscles (Nixon, 1988). The majority of 
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the systemic flow is delivered to the visceral organs. However, muscle oxygen 
consumption increases to almost 50 times the resting value during exercise (Chapman et 
al., 1967). During muscular contraction or exertion, there is an increase in sympathetic 
nerve activity in the viscera, kidneys, skin, and resting muscles. The brain, unlike all 
other organs, is the only organ that preserves a constant blood flow under all conditions 
(Nixon, 1988) (Figure 7). The lack of increased oxygen consumption in other organs 
makes it possible for all but some of the cardiac output to be diverted away from these 
organs and towards skeletal muscles.  
There are several different ways that this critical redistribution of blood flow from 
inactive regions to active skeletal muscles takes place. As mentioned earlier, there is 
increased sympathetic nerve activity in the visceral organs and skin. This means that 
there is a reflex vasoconstriction of the arterioles that supply visceral organs. There is 
also an initial vasoconstriction in the arterioles that supply the skin, after which 
sympathetic stimulation of the skin leads to vasodilation for appropriate thermoregulation 
purposes (Fox et al., 1993). As the duration of exercise increases, it becomes important 
for cutaneous arterioles to vasodilate, which maintain an increased blood flow to give off 
the extra heat that is generated. It has also been previously proposed that there is a reflex 
vasodilation of the arterioles supplying active skeletal muscles during the onset of 
exercise (Nixon, 1988). Finally, it is now believed there is also profound local 
vasodilation in the microvasculature of active muscles that is caused by increases in local 
temperature, PCO2, lactic acid levels, and a decrease in PO2 (Fox et al., 1993). All of 
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these mechanisms are intertwined with both neural and humoral reflexes that increase 
stroke volume, heart rate, and venous return. 
 
Figure 7: Redistribution of blood flow from inactive regions to active muscles is an 
essential adaptation to exercise. The brain is unique in that it maintains constant blood flow 
despite the condition. Blood flow to the kidney decreases but does not cease. Blood flow to the 
skin increases as the intensity of exercise increases but decreases at maximum work levels. Figure 
reproduced from Physiology of muscular exercise, (Chapman et al., 1967). 
 
The autonomic nervous system, which consists of the sympathetic and 
parasympathetic branches, independently controls secretion by the visceral organs, 
urinary output, body temperature, heart rate, adrenal gland secretion, and blood pressure. 
The sympathetic nervous system also plays an important role in muscular activation. It 
regulates skeletal muscle function by altering the membrane polarity, releasing 
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acetylcholine from the motor end plate, promoting the release and reuptake of calcium, 
and also regulating glucose and protein metabolism (Roatta & Farina, 2010). These 
sympathetic functions are summarized in Figure 8. Activation of the sympathetic nervous 
system results in the release of norepinephrine from nerve terminals and the hormonal 
release of epinephrine from the adrenal medulla. These catecholamines increase in 
concentration in the blood plasma during exercise and bind adrenergic receptors on 
vascular smooth cells to modulate different muscle functions (Roatta & Farina, 2010).  
 
 
Figure 8: Actions of catecholamines on skeletal muscle cells. 1) Glucose and protein 
metabolism. 2) Enhancement of the Na+/K+ (sodium potassium) pump. 3) ACh (acetylcholine) 
release at the neuromuscular junction. 4) Ca2+ (calcium) release and reuptake by the SR 
(sarcoplasmic reticulum). AR, adrenergic receptor; EPI, epinephrine; NE, norepinephrine. Figure 
reproduced from Sympathetic Actions on the Skeletal Muscle, (Roatta & Farina, 2010) 
Evidence from previous studies has shown that there is tonic sympathetic 
vasoconstriction in skeletal muscle microvascular beds through the neuronal release of 
noradrenaline (NA), neuropeptide Y (NPY), and adenosine triphosphate (ATP) (Clifford 
& Hellsten, 2004). These substances bind to their appropriate receptors on vascular 
smooth muscle cells (α1 and α2, Y1, and P2X respectively) to cause vasoconstriction 
(Figure 9). This vasoconstrictor response, however, varies depending on vessel location 
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and vessel diameter. It has been shown that stimulation of the sympathetic nerve elicits 
greater vasoconstriction in smaller, distal arterioles than larger arterioles and feed arteries 
(Moore et al., 2010). 
 
Figure 9. Sympathetic actions on vascular smooth muscle. Preganglionic sympathetic 
nerve fibers release ACh, whereas postganglionic sympathetic nerve fibers release many different 
substances, such as NE, ATP, and NPY. These factors bind their appropriate receptors on 
vascular smooth muscle cells and/or the endothelium to cause vasodilation or vasoconstriction. 
ACh, acetylcholine; NE, norepinephrine; α1, alpha1 adrenergic receptor; α2, alpha2 adrenergic 
receptor; β2 , beta2 adrenergic receptor; M, muscarinic receptor; P2x, ligand gated ion channel 
purinergic receptor; P2y, G-protein coupled purinergic receptor. Courtesy of Philip S. Clifford, 
PhD. 
 
Researchers have shown that proximal arterioles, specifically first order (1A) to 
third order (3A) arterioles, are dominated by adrenergic control, whereas NPY and ATP 
exert their effects mainly at the pre-capillary terminal arterioles (Faber, 1988b; Moore et 
al., 2010; Ohyanagi et al., 1991). The cremaster muscle of the rat has been utilized in vivo 
to study the functional distribution of α1 and α2 adrenergic receptors in arterioles using 
	21 
NA and its analogues as stimulants (Faber, 1988b; McGillivray-Anderson & Faber, 1991; 
Ohyanagi et al., 1991). These studies have indicated that stimulation of α1 adrenergic 
receptors evokes a greater vasoconstriction in larger, first order arterioles (the first 
arterioles to branch off feeding arteries and enter the muscle fibers), whereas activation of 
α2 adrenergic receptors evokes a greater response in smaller, third order arterioles.  
One limiting factor in these studies, however, is the fact that all were performed in 
the cremaster muscle, which may not be representative of all skeletal muscle. In fact, 
similar studies performed on the gluteus maximus muscle of rats yielded contrasting 
results with α1 receptor activity predominating in smaller arterioles and α2 receptor 
activity predominating in larger arterioles (Moore et al., 2010). Due to this, it is uncertain 
if the functional distribution of the different α adrenergic receptors can be generalized to 
all skeletal muscle cells.  
Unlike α2 adrenergic receptors, which have high functionality up to third order 
arterioles, Y1 receptors have increased activity in 5A arterioles. This demonstrates a 
significant role of NPY in regulating distal arterioles in the muscle microvasculature (Al-
Khazraji et al., 2015). It has been established through studies in dogs and humans that 
NPY increases vascular resistance and causes vasoconstriction in resting skeletal muscles 
(Buckwalter et al., 2004). These studies have also established that with increased 
sympathetic nerve activity during exercise, there is an increase in the concentration of 
NPY in the skeletal muscle vasculature, suggesting a possible vasoconstrictor role for this 
neurotransmitter in exercising muscles as well. 
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Similar to how the vasoconstricting effects of NPY are order-dependent, the 
effects of ATP through the binding of P2X receptors are more prominent in 4A arterioles 
than other order arterioles (Al-Khazraji et al., 2015). However, ATP not only binds P2X 
receptors located abluminally on vascular smooth muscle cells causing vasoconstriction, 
it also binds P2Y receptors located intraluminally on vascular endothelial cells causing 
vasodilation (Burnstock & Kennedy, 1985). Interstitial ATP can also mediate 
vasodilation via degradation to adenosine, a potent vasodilator. Due to this, at low 
concentrations ATP causes vascular vasoconstriction by binding to P2X receptors on 
vascular smooth muscle cells. At high concentrations, however, it causes vasodilation by 
diffusing across from the interstitial space to produce P2Y-mediated vasodilation. Apart 
from that, it can also induce the formation of nitric oxide and prostacyclin, which are 
potent vasodilators (Al-Khazraji et al., 2015). 
Functional Sympatholysis 
 The term ‘functional sympatholysis’ was first invented by Remensnyder who 
found that through stimulation of the lumbar sympathetic chain, muscular activity was 
associated with both an increased oxygen consumption and subsequent decrease in 
vascular resistance (Remensnyder et al., 1962). This important, yet controversial, concept 
ultimately describes the attenuation of sympathetic adrenergic vasoconstriction during 
muscular contraction. It is this mechanism that is responsible for matching of the increase 
in metabolism with an increase in blood flow during exercise (Remensnyder et al., 1962). 
During exercise there is an elevation in sympathetic nerve activity, which is essential for 
proper blood flow and oxygen delivery to contracting skeletal muscle. At the same time, 
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this increase in sympathetic vasoconstrictor activity is also necessary to limit blood flow 
to inactive tissues during exercise and thus maintain appropriate blood pressure with the 
profound vasodilation in active skeletal muscle vasculature. 
 Accompanying exercise is an increase in sympathetic nerve activity to skeletal 
muscle that works mainly by the muscle metaboreflex (Mitchell et al., 1983). Muscle 
contraction results in the release of various metabolic by-products that chemically 
activate afferent nerves in the muscle interstitium. This response signals to vasomotor 
neurons in the medulla that the working muscle cells require an increased blood flow to 
meet their O2 demands. As a consequence, there is increased efferent sympathetic nerve 
activity that targets not only inactive tissues but also active skeletal muscle (Savard et al., 
1987). While it is reasonable to assume that sympathetic vasoconstriction in resting 
muscle helps divert the cardiac output to where it is most needed and helps maintain 
arterial blood pressure, its functional significance in active muscles has been difficult to 
clarify. 
 The notion that there is increased sympathetic nerve activity in active muscle as 
well as profound vasodilation appears to be an important enigma to consider. It is 
understood that due to the high metabolic demands of active muscle cells, most of the 
cardiac output is diverted away from inactive tissues to active skeletal muscle, and this is 
established through an increase in blood flow and vasodilation at the onset of muscular 
contraction (Nixon, 1988). However, there is also considerable sympathetic 
vasoconstriction in the vascular beds of active muscle, which maintains blood pressure 
within an appropriate range (Nixon, 1988). Numerous studies have been carried out over 
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the years to investigate the role and impact of sympathetic vasoconstriction in active 
skeletal muscle vasculature, some of which will be discussed next. 
 The methods by which functional sympatholysis have classically been studied 
include directly observing sympathetic nerve activity or norepinephrine spillover, 
interrupting sympathetic nerve activity, or blocking sympathetic postsynaptic receptors. 
Even though there is strong evidence that indicates there is increased sympathetic nerve 
activity in active skeletal muscle and norepinephrine spillover, it has proven difficult to 
illustrate sympathetic nervous system limitation of blood flow in exercising muscle (Hill 
et al., 1996). Investigations that have served to interrupt sympathetic nerve activity in 
both animals and humans have found that there is an increase in vascular conductance or 
blood flow in the working musculature after the blockage, suggesting an important role of 
the sympathetic nervous system in controlling blood flow during contraction (Donald et 
al., 1970; Joyner et al., 1992; Lee et al., 2000). Other studies that have tried to block 
postsynaptic receptors have done so using alpha-adrenergic receptor antagonists, such as 
prazosin and phentolamine. These reports have established that there is an instantaneous 
and persistent increase in blood flow when sympathetic nerve activity is not influencing 
active muscle, thus indicating that there is definite alpha adrenergic restraint of blood 
flow to active skeletal muscle during exercise (Buckwalter et al., 1997; O'Leary et al., 
1997; Williams et al., 1978). 
 Along with the classical studies, which have focused principally on adrenergic 
receptors, there have also been studies dedicated to investigating non-adrenergic 
sympathetic receptors. It has been validated that skeletal muscle vasculature also contains 
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P2X and Y1 receptors (Buckwalter et al., 2004; Buckwalter et al., 2004; Delorey et al., 
2012). In fact, blocking these receptors with various antagonists has similarly 
demonstrated an increase in blood flow, as seen with adrenergic receptor blockage. This 
indicates that the sympathetic nervous system facilitates the release of both ATP and 
NPY in the skeletal muscle vasculature, signifying a potential role for both of these 
substances in exercise-related sympathetic vasoconstriction (Buckwalter et al., 2005; 
Buckwalter et al., 1997; Buckwalter et al., 2004; Delorey et al., 2012; Taylor et al., 
2008). All of these studies have made it clear that sympathetic nerve activity is present in 
both active and inactive skeletal muscle and that this sympathetic vasoconstriction is 
mediated by both adrenergic and non-adrenergic receptors located on the muscle 
vasculature. 
 Recently, a lot of time and effort has been put into figuring out the mechanism by 
which sympatholysis occurs. Some have postulated that the phenomenon might work 
through a pre-junctional mechanism, such that metabolic by-products of muscular 
contraction may inhibit the release of norepinephrine from nerve terminals (Burcher & 
Garlick, 1973). A few metabolites that have previously been considered to have this 
inhibitory effect are adenosine, potassium, hydrogen ions, prostaglandins, and even nitric 
oxide (Anderson & Faber, 1991). Despite substantial evidence pointing to these 
metabolic substances, manipulation of adrenergic receptors has shown that the 
attenuation in sympathetic vasoconstriction quite possibly concerns downstream receptor 
activation and transduction pathways. 
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 Perhaps the greatest amount of research has been devoted to understanding the 
contraction-related diminished responsiveness of α1 and α2 adrenergic receptors. As 
previously mentioned, it was demonstrated that in the rat cremaster muscle, α1 adrenergic 
receptor activity was greater in larger arterioles whereas α2 adrenergic receptor activity 
was greater in smaller ones (Faber, 1988a). Unlike vasoconstriction mediated by α1 
adrenergic receptors, vasoconstriction by α2 adrenergic receptors appears to be more 
directly affected by the muscular environment during contraction. α2 adrenergic receptors 
are not only affected by chemical changes, such as pH, hypoxia, or ischemia, but also 
display a greater attenuation in sympathetic vasoconstriction during exercise (Faber, 
1988b). Even though many different experiments have validated these findings, it is not 
the case in every species and muscle group. For example, in dogs, dynamic exercise 
resulted in the attenuation of sympathetic vasoconstriction through both α1 and α2 
adrenergic receptors, even though the response was graded for α2 adrenergic receptors 
(Buckwalter et al., 1998). Finally, in one particular human study, both types of alpha-
adrenergic receptors revealed a similar reduction in sympathetic vasoconstriction 
(Rosenmeier et al., 2003). The inconsistency in these different studies might be related to 
a differential distribution of these alpha-receptors in different species and muscle types, 
but a definitive explanation is lacking at this time. 
 Currently, it is generally agreed that functional sympatholysis does exist, but the 
concrete mechanism underlying this important phenomenon is still under consideration. 
Both metabolite-related and non-metabolite-related mechanisms have been postulated to 
be responsible for this response, but the present data is not sufficient to rule out one over 
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the other. Some of the proposed mechanisms for functional sympatholysis are described 
below. 
Proposed Mechanisms of Functional Sympatholysis 
 A few recent studies performed in humans have revealed an attenuation of 
sympathetic vasoconstriction as early as one second into muscular contraction (DeLorey 
et al., 2002; Tschakovsky & Hughson, 2003; Tschakovsky et al., 2002). This is 
noteworthy because in order for sympatholysis to be metabolite-driven, metabolites 
would need to be released by skeletal muscle fibers, diffused into the extracellular space, 
and increased to sufficient concentrations to have a significant inhibitory effect, a process 
that likely exceeds one second in duration (Thomas et al., 1994). Interestingly, potassium 
concentrations have been shown to rapidly increase in the interstitial fluid in response to 
contractions as short as one second (Hník et al., 1976). Through voltage dependent K+ 
channels, active skeletal muscle cells release K+ during muscular contraction in a process 
known as excitation-contraction coupling. As mentioned previously, increases in 
extracellular K+ levels mediate hyperpolarization of vascular smooth muscle, leading to 
vasodilation and an increase in blood flow. This, along with studies executed to directly 
test this which have also shown that higher doses of K+ attenuate sympathetic 
vasoconstriction (Beaty & Donal, 1977), would then represent a possible mechanism for 
functional sympatholysis. 
 There is also evidence that supports a role for nitric oxide in attenuating 
sympathetic vasoconstriction in exercising muscle. For example, studies with rats did not 
demonstrate a sympatholytic effect when there was also a deficient nitric oxide synthase 
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(NOS) present, indicating an important role for NO in propagating this event (Thomas & 
Victor, 1998). In fact, part of the sympathetic vasoconstriction was reestablished in 
contracting rat hindlimb after inhibiting NOS. These results, however, are not applicable 
to humans as mixed data has been yielded, and additionally because exogenous NO was 
not shown to contribute to sympatholysis (Tschakovsky et al., 2002). 
 Data has also suggested that ATP-sensitive potassium (KATP) channels may play a 
role in diminishing sympathetic adrenergic vasoconstriction. KATP channels are a class of 
K+ channels located on vascular smooth muscle cells, and their activation leads to an 
increased efflux of K+, subsequent hyperpolarization of the membrane, and relaxation of 
vascular smooth muscle. This membrane hyperpolarization would result in less 
intracellular Ca2+ influx from voltage-dependent Ca2+ channels and would therefore have 
an inhibitory effect on adrenergic vasoconstriction (Tateishi & Faber, 1995; Thomas, 
Hansen, & Victor, 1997). A previous investigation that blocked these vascular KATP 
channels in rat hindlimb arterioles found that adrenergic vasoconstriction was restored 
after the blockade (Thomas et al., 1997). 
 Another factor that could be involved is temperature. As a consequence of any 
exercise or muscular contraction, there is production of heat. It could be that as muscle 
temperature rises during contraction, there is decreased responsiveness of certain vascular 
receptors, causing the attenuation in sympathetic nerve activity observed (Cooke et al., 
1984; Faber, 1988a; Flavahan et al., 1985; Massett et al., 1998). One study, investigating 
the role of temperature in mice tail arteries, showed that there is a specific subclass of α2 
adrenergic receptors located in the skin vasculature that translocates to the plasma 
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membrane and in cold conditions show an increased responsiveness to norepinephrine 
(Chotani et al., 2000). This evidence supports the possibility that the opposite holds true 
when the temperature rises, thus revealing another potential mechanism by which 
functional sympatholysis occurs. However, no research has been done currently to 
validate this hypothesis. 
 Finally, the reduced sympathetic vasoconstriction might be due to a nonspecific 
blood flow elevation. In order to assess this claim, many different studies have 
administered pharmacological agents to cause vasodilation and obtain a flow level similar 
to the one that exists during contraction (Dinenno & Joyner, 2003; Thomas et al., 1994, 
1997; Thomas & Victor, 1998; Tschakovsky et al., 2002; VanTeeffelen & Segal, 2003). 
Surprisingly, these various studies have consistently shown that pharmacological 
manipulations resulting in increased flow fail to exhibit sympatholysis. 
There is one exception to the above scenario, however, and it has to do with ATP. 
One study found that both the infusion of ATP and the presence of exercise in the human 
leg completely eliminated sympathetic vasoconstriction, but adenosine did not 
(Rosenmeier et al., 2004). A similar study performed on the human forearm also 
demonstrated inhibition of sympathetic vasoconstriction when ATP was infused, but not 
adenosine (Kirby et al., 2008). These studies point to a significant role of ATP in 
functional sympatholysis, such that ATP can bind to P2Y receptors on vascular 
endothelial cells leading to membrane hyperpolarization of vascular smooth muscle, 
subsequent vasodilation, and an increase in blood flow (Kirby et al., 2008; Rosenmeier et 
al., 2004). Although the source of ATP is not clear at this point, the current data supports 
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the role of intraluminal ATP in mediating the paradoxical phenomenon of functional 
sympatholysis. 
The single most important study, however, that has led to the basis of this paper 
and its hypothesis is the recent investigation carried out by Hearon and colleagues 
directly linking the endothelium to the attenuation of sympathetic adrenergic 
vasoconstriction (Hearon et al., 2016). This study is most relevant because it is the first 
study performed on humans that sought to identify endothelium-dependent regulation of 
sympathetic vasoconstriction in exercising skeletal muscle. The α1-adrenergic receptor 
agonist, phenylephrine (PE) was infused during the concurrent infusion of endothelium-
dependent vasodilators, ATP and ACh, and also during the infusion of endothelium-
independent vasodilators, sodium nitroprusside (SNP) and potassium chloride (KCl), 
during moderate handgrip exercise. The endothelium-dependent vasodilatory signals 
caused a significant reduction in sympathetic adrenergic vasoconstriction, while the 
endothelium-independent vasodilators did not. It seems clear from these conclusions that 
there is a well-defined mechanism by which the endothelium contributes to 
sympatholysis, and this discovery may lead to a much better understanding of different 
physiological conditions and cardiovascular abnormalities. 
Specific Aim 
 The purpose of this paper is to hypothesize a potential role for the vascular 
endothelium in attenuating sympathetic adrenergic vasoconstriction, with the hypothesis 
being that the endothelium is primarily responsible for producing sympatholysis. Two 
different vasodilatory drugs, ATP and Ado, as well FMD will be discussed in relation to 
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sympatholysis. Both ATP and Ado have been utilized in past studies to evoke arteriolar 
vasodilation, while alpha agonists have been infused during their vasodilatory responses. 
The magnitude of vasoconstriction observed has allowed investigators to make 
conclusions regarding the relationship between the endothelium and sympatholysis. 
Additionally, FMD will be included in this discussion as an alternative indicator that this 
process is endothelium-dependent. In order to confirm this hypothesis, both ATP and 
FMD should be sympatholytic agents whereas Ado should not be. Some of the potential 
results and their implications will be discussed later. 
 As stated previously, ATP and Ado are two potent vasodilatory agents with 
different mechanisms of action. ATP binds to P2Y receptors located on vascular 
endothelial cells to mediate vasodilation (Kirby et al., 2008; Rosenmeier et al., 2004; 
Rosenmeier et al., 2008). Adenosine, on the other hand produces vasodilation by direct 
action on the vascular smooth muscle through P1 receptors (Ray et al., 2002). It is also 
known that any flow through a vessel leads to a vasodilatory response because it is the 
endothelial response to shear stress (Shipley et al., 2005). Endothelial cells release 
different vasoactive substances as a consequence of shear stress, and this leads to 
vasodilation (Pohl et al., 1986). Therefore, these three different vasodilatory stimuli—
ATP, Ado, and FMD— will represent the vasodilatory and hyperemic response that is 
present in many different types of physiological scenarios, such as exercise and disease 
states. 
 Since the exact functional distribution of α1-adrenergic receptors and α2-
adrenergic receptors in different species and muscle fiber types still remains uncertain, 
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the focus of this paper will be on α1-adrenergic receptor responsiveness. Similar to the 
study by Hearon mentioned earlier, the α1-agonist PE will be used to discuss adrenergic 
vasoconstriction against the vasodilation caused by FMD, ATP, and Ado. The primary 
purpose of choosing PE for this proposition is due to the fact that it has been shown to be 
highly selective in regards to receptor activation (Moore et al., 2010) and has been widely 
used in similar studies. If these three different factors promote arteriolar vasodilation and 
that response was overlapped with sympathetic vasoconstriction, it could mimic the 
sympatholytic effect that is desired. The results obtained from a study like this would 
help further indicate what underlying processes are taking place to produce such an 
important yet paradoxical event.
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PROPOSED EXPERIMENTAL APPROACH 
Animals 
Although the broad purpose of such a study would be to gain a deeper 
understanding into physiological conditions that take place in humans, it would not be 
possible to carry out these manipulations in human subjects. Therefore, the use of a 
rodent species, such as mice or rats, would make the most plausible use of resources. The 
use of a rodent species, as most other similar studies have done in the past, would also be 
most representative of human cardiovascular physiology and disease. For the purpose of 
this hypothesis and hypothetical study, the rat species and its cremaster muscle arterioles 
will be used. 
Cremaster Muscle Preparation 
On the day of any experiment, a rat would be anesthetized by an intraperitoneal 
injection of sodium pentobarbital, supplemented if necessary to prevent withdrawal from 
toe pinch. Through a carefully executed surgical approach, the right and left cremaster 
muscles, which are extensions of the internal oblique and transverse abdominus muscles 
that surround the testicles, would be excised and prepared in situ for microvascular 
observation. The original dose of anesthesia administered to the rat would then be 
supplemented with an additional dose of sodium pentobarbital to euthanize the rat. The 
excised and exposed muscle tissue should be placed in a cold physiological based saline 
solution (PSS) that contains the appropriate concentrated solutes, osmolality, and pH 
while waiting for experimentation. 
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Vessel Preparation 
 Cremaster muscle (1A) arterioles would be dissected using the guidance of a 
dissection microscope and cannulated on a vessel chamber system with micropipettes of 
matched resistance. After cannulation, the microvessel chamber should be transferred to 
the stage of an inverted microscope for observation. This microscope will be connected to 
a video caliper system that can be used to measure intraluminal diameter. The cremaster 
arterioles should be pressurized to 70mgHg using two independent hydrostatic pressure 
reservoirs that are filled with deionized water, and the initial diameters should be 
recorded. The vessel bath would also be connected to a peristaltic pump, which can 
continuously pump fresh superfusate through a heat exchanger into the bath for constant 
superfusion. At the appropriate bath temperature, the vessels would be given around 30 
minutes to develop spontaneous tone. Only those arterioles that develop tone should be 
included in the data set and analysis. See Figure 10 and Figure 11 below for a general 
depiction of a possible experimental design. 
 
Figure 10: A cremaster arteriole as viewed from the dissection microscope. Courtesy 
of Philip S. Clifford, PhD. 
	35 
 
Figure 11: The experimental setup. A Lucite chamber with the vessel embedded rests on the 
platform of an intravital microscope for observation. Two pressure reservoirs filled with 
deionized water also lie next to the chamber for a pressure reading. The system is connected to a 
video caliper system, which is connected to a computer for recording. Courtesy of Philip S. 
Clifford, PhD. 
 
 If an arteriole develops tone (60% initial diameter) and is stable at it for at least 10 
minutes, an appropriate volume and concentration of ACh should be administered to the 
vessel bath using a transfer pipette. Since ACh is a potent vasodilator that causes 
endothelial cell hyperpolarization and relaxation, an appropriate vasodilatory response 
should be observed to confidently confirm a viable vascular endothelial layer. Once the 
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vasodilatory response has occurred and stabilized, the chamber can be washed out with 
superfusate to compel the vessel to regain basal tone. Only the arterioles that respond to 
ACh and also return back to their appropriate tonic ranges should be included in the 
study. 
Experimental Drugs 
 Both the vasodilatory drugs that would be used in this study, ATP and Ado, 
should be made fresh daily and dissolved in warmed PSS at their appropriate 
concentrations and volumes for administration into the vessel. The concentration of ATP 
may be determined from a former study that investigated the role of ATP in regulating 
local blood flow in skeletal muscle (Mortensen et al., 2009), whereas the concentration of 
Ado can be determined from a study that tried to investigate whether Ado was a 
sympatholytic agent (Heckle, 2014). For example, 10-4 M concentrations of both these 
drugs can be used. These drug dosages can be instilled into pressure lines to be ready for 
intraluminal administration. The height of the two pressure reservoirs can then be 
adjusted to produce a pressure gradient that would allow the drug to flow into the lumen 
of the vessel. 
PE should also be prepared in its desired concentration and volume for delivery 
into the vessel bath. In order to deliver a PE dose-response curve it would be reasonable 
to have varying concentrations of this agonist, for example ranging from 10-8 M to 10-4 
M. These PE concentrations and the volumes administered to the vessel bath may be 
determined from physiological resting levels and levels higher than that in order to 
maximize vasoconstriction (Mortensen et al., 2012; Stratton & Halter, 1985). 
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To assess maximal vasodilatory capacity, at the end of the experiment the vessel 
bath should be incubated with Ca2+ free PSS buffer that is prepared beforehand with its 
appropriately concentrated solutes, osmolality, and pH. This would therefore provide 
relevant experimental data, which includes the maximal luminal diameter, to utilize in the 
statistical analysis portion of the study. 
FMD 
 In order to establish FMD in the arterioles, a pressure gradient can be formed 
through altering the height of the two pressure reservoirs next to the vessel chamber. In 
order to obtain 60-80% maximal dilation, the pressure gradient can be elevated in a 
stepwise fashion starting at 2 cmH2O and increasing it until the desired vasodilatory 
response is observed. The arteriolar diameter changes should be recorded at the end of 
each incremental step. To ensure that flow is going through the vessel, the volumes in the 
pressure reservoirs should be periodically tracked. Once the intraluminal diameter is 
about 60-80% of the initial diameter, the vessel is ready to receive the α1-agonist. 
 To test the arteriolar vasodilation with FMD against sympathetic adrenergic 
vasoconstriction, PE should be administered to the arteriole while FMD is maintained at 
60-80% dilation. The PE doses, starting with 10-8 M and ending with 10-4 M, can be 
pipetted into the chamber with their respective volumes at an appropriate time interval 
while the intraluminal diameter changes are tracked and recorded at each step increase in 
dose. 
 Following the PE-mediated sympathetic vasoconstriction observed with FMD, the 
vessel should be allowed time to return to its basal tone through continuous superfusion. 
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Once a basal tone is established, the vessel bath consisting of warm PSS should be 
replaced with Ca2+ free PSS in order to allow the vessel to maximally dilate. The vessel 
should be given sufficient time to respond appropriately, and once the final diameter 
reading is recorded the vessel can be taken down. 
ATP 
 To test the sympatholytic effects of ATP against PE-mediated sympathetic 
vasoconstriction, ATP should be allowed to enter the vessel lumen from the pre-filled 
pressure line by establishing a small pressure gradient. Once ATP is in the vessel lumen, 
a stable vasodilation should be observed. Pressure can then be stabilized back to 
70mmHg, and the ATP can be trapped intraluminally for a few minutes to allow the 
vessel to stabilize in diameter. 
 The change in luminal diameter in response to ATP should be noted before the PE 
curve is initiated. Once again, starting from 10-8 M PE and increasing up to 10-4 M PE 
using an appropriate time interval, a PE curve can be implemented on the maximal 
dilation caused by the ATP. The vessel diameter changes should be recorded before each 
dose increase in PE. After completion of the PE curve, the vessel should be allowed time 
to regain tone by washing with superfusate. Once that is achieved, the warm PSS in the 
vessel bath can be replaced with Ca2+ free PSS, and the vessel should be allowed 
sufficient time to maximally dilate. After the final recording of this diameter, the 
experiment can be discontinued. 
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Adenosine 
Similarly to ATP, the appropriate concentration and volume of Ado should be 
pulled up into an external pressure line and connected to the chamber until it is ready for 
use. Using a small pressure gradient, Ado can be permitted to flow into the vessel lumen, 
while closely monitoring the flow reading at the same time. Once Ado is inside the vessel 
lumen, it can be trapped intraluminally, and the pressure can be stabilized back to 
70mmHg. After a few minutes to warrant stabilization of the vessel diameter, a PE curve 
can be applied against the Ado-mediated vasodilation. Once this is complete, and the 
respective diameter changes have been recorded, the vessel should be given time to 
regain tone. Lastly, the vessel should be allowed to bathe in Ca2+ free PSS for some time, 
and the final maximal diameter should be recorded before discontinuing the 
experimentation.  
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DISCUSSION 
 
The broad intent of the proposed study is to gain a deeper understanding of the 
endothelium’s role in attenuating sympathetic adrenergic vasoconstriction. The 
hypothesis is that both FMD and the presence of intraluminal ATP will cause a reduction 
in sympathetic vasoconstriction, but adenosine will not. Since the vasodilatory effect 
observed when flow is produced, and the manner by which intraluminal ATP causes 
vascular relaxation, involve endothelial processes this would denote a relevant role of the 
endothelium in eliciting sympatholysis. Adenosine, on the other hand, potently causes 
vasodilation of the vascular wall by processes that primarily involve vascular smooth 
muscle cells and is not expected to affect sympathetic vasoconstriction. The possible data 
obtained from this study may or may not support the endothelium’s participation in 
evoking sympatholysis. 
 In order to mimic this sympatholytic effect, PE was chosen as the sympathetic 
adrenergic receptor agonist. Even though the activation of the sympathetic nervous 
system results in the release of many different neurotransmitters, it is accepted that 
norepinephrine is the primary neurotransmitter involved in exercise-related sympathetic 
vasoconstriction (Buckwalter & Clifford, 1999). With this in mind and the fact that PE is 
an analogue of norepinephrine, the use of PE as a receptor agonist will not limit the 
interpretation of the data. 
In regards to receptor responsiveness, only α1-adrenergic receptor stimulation will 
be studied here due to the vast amount of conflicting data on the functional distribution 
between α1 and α2-adrenergic receptors. Many previous studies have shown that both α1 
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and α2-adrenergic receptor activities are blunted during exercise in humans (Dinenno & 
Joyner, 2003; Rosenmeier et al., 2003). However, it should be noted that other 
experiments involving exercise and humans have demonstrated that α2-adrenergic 
receptor responsiveness is significantly more blunted during exercise than is α1-
adrenergic receptor responsiveness (Wray et al., 2004). Along with humans, there have 
been similar findings in different animal models as well (Anderson & Faber, 1991; 
Buckwalter et al., 2001). 
 If the proposed hypothesis in the study is demonstrated to be valid, the principal 
findings of this investigation would be that intraluminal ATP infusion blunts sympathetic 
adrenergic activity, whereas adenosine infusion does not. In other words, ATP is capable 
of sustaining profound vascular vasodilation in the skeletal muscle microvasculature even 
with a central increase in sympathetic nerve activity, an effect not observed with 
adenosine. Additionally, FMD, which is another promoter of endothelium-dependent 
vasodilation, will also diminish sympathetic vasoconstriction. These findings will then 
further provide evidence implying that sympatholysis does in fact occur by means that 
primarily involve the endothelium. 
 If, however, the results and data analysis do not support the proposed hypothesis, 
it will be difficult to confine the process of sympatholysis primarily to the endothelium at 
this time. This could mean that adenosine demonstrates a sympatholytic effect, ATP does 
not demonstrate a sympatholytic effect, or that FMD does not impact sympatholysis. This 
would then warrant further investigation into the topic and would suggest that other 
factors may be involved. 
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 The reason FMD is included as the third vasodilatory stimulus is to hopefully 
provide one more indicator that sympatholysis is an endothelium-mediated process. To 
date, no other investigations have used FMD as a stimulus to directly test the 
endothelium’s role in sympatholysis; therefore, this would make a unique contribution to 
the current body of research on this topic. As noted above, FMD describes the ability of a 
blood vessel to dilate in response to an elevation in blood flow. It has been primarily 
shown to be an endothelial process through studies that have damaged the endothelium 
and consequently demonstrated a complete abolishment in the flow-mediated 
vasodilatory response (Pohl et al., 1986). Thus, using FMD as an alternative vasodilatory 
stimulus to mimic sympatholysis would directly test the direct requirement of the 
endothelium in inducing sympatholysis. 
 Previous experimental studies involving humans and rodents have lucidly 
exposed the exceptional ability of contracting skeletal muscle to attenuate sympathetic 
vasoconstriction, a phenomenon believed to regulate muscle flood flow and oxygen 
delivery when sympathetic nervous system activity is present (Joyner et al., 1992; 
VanTeeffelen & Segal, 2003). Agents such as adenosine, NO, and PG’s have been 
postulated to be responsible for this attenuation; however, the definitive mechanism has 
been difficult to elucidate in humans (Dinenno & Joyner, 2003). Recent studies that have 
directly tested the effects of certain vasodilatory agents against sympathetic 
vasoconstriction are important in distinguishing that not all vasodilatory substances are 
capable of abolishing sympathetic adrenergic activity. For example, a study similar to the 
present study demonstrated that vasodilators sodium nitroprusside (SNP) and adenosine 
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played no part in diminishing sympathetic vasoconstriction in humans, whereas 
exogenous ATP infusion and exercise did have a significant impact (Rosenmeier et al., 
2004). The numerous studies discussed have revealed that sympatholysis does in fact 
occur in contracting muscle and that the mechanism behind it encompasses more than 
simply the presence of local vasodilators and muscle metabolites. 
 The fundamental role of ATP in both exercise hyperemia and sympatholysis 
seems possible due to the large amount of experimental data that suggests it can be 
released by erythrocytes in response to increased deoxyhemoglobin levels. This idea 
appears attractive because ATP has a very short half-life, and erythrocytes become 
deoxygenated close to the active muscle vasculature, eliciting the release and activation 
of ATP. This would also allow the manifestation of sympathetic vasoconstriction in those 
resistance vessels that are not actively engaged, fostering an efficient balance between the 
oxygen demand and oxygen delivery in the muscle microvasculature (Calbet et al., 2006). 
Apart from red blood cells, however, other sources of ATP may include endothelial cells, 
the local circulation, or the contracting skeletal muscle cells. 
 Regardless of the source of ATP, the exact mechanism explaining the execution 
of its sympatholytic effect in the microvasculature has been difficult to determine, 
although several mechanisms have been proposed. One such mechanism, and also the 
mechanism to be tested in the proposed study, is the binding of ATP to P2Y receptors on 
vascular endothelial cells to promote vascular smooth muscle cell hyperpolarization, thus 
blunting sympathetic adrenergic vasoconstriction. Supporting this hypothesis, previously 
conducted studies have shown that the vasodilation associated with ATP is independent 
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of other factors, such as NO and PGs (Dinenno & Joyner, 2003; Hansen et al., 2000). 
However, the data has not been consistent in every study, suggesting that other 
modulatory factors are likely involved.  
 Another possibility that has been considered is that ATP-mediated vasodilation is 
the result of ATP degradation to Ado, a potent vasodilator (Mortensen et al., 2009). This 
suggests that Ado might exert its vasodilatory effects by binding to receptors located on 
the vascular endothelium or on vascular smooth muscle cells. Nonetheless, the existing 
data supporting this hypothesis is also conflicting, warranting further investigation. 
 Even though new discoveries are expanding our understanding about 
sympatholysis, it is by no means clear of all controversy. Even though the main emphasis 
here was placed on postjunctional α-adrenergic receptor responsiveness, a potential 
prejunctional mechanism cannot be ignored. Such a mechanism might include a 
decreased release of sympathetic neurotransmitters during muscular contraction due to 
some inhibitory metabolites, such as adenosine, potassium, hydrogen ions, 
prostaglandins, or even nitric oxide (Anderson & Faber, 1991). In fact, one early study 
proposed that inhibitory metabolites were in fact the main reason that sympathetic 
responses were significantly more reduced by exercise (Burcher & Garlick, 1973). 
Although a prejunctional mechanism was not given much consideration here, it must be 
recognized that it may also play a role in sympatholysis. 
 Another controversial aspect of sympatholysis relates to the differential 
distribution of α1 and α2 adrenergic receptors throughout the skeletal muscle vasculature. 
The emphasis here was placed on α1 adrenergic receptor responsiveness, but it is 
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important to remember there is a large number of conflicting data that support a role for 
both types of adrenergic receptors in sympatholysis. For example, one study in the rat 
hindlimb demonstrated the attenuated sympathetic response to be solely due to impaired 
α2 responsiveness, with no link to α1 adrenergic receptor responsiveness (Thomas et al., 
1994). In contrast to that, a different study found diminished vascular responses in both 
α1 and α2 adrenergic receptors during exercise (Buckwalter & Clifford, 2001). Studies 
like these have made it clear that there is a differential sensitivity in both types of 
receptors, but whether one is more directly involved in attenuating sympathetic 
vasoconstriction still remains elusive. 
 Finally, some of the controversy in the existing literature is a consequence of 
inappropriate expression of data. There is a reciprocal relationship between vascular 
conductance and vascular resistance; therefore, vascular conductance and flow share a 
linear relationship (Buckwalter & Clifford, 2001). In the present literature, there has often 
been a misuse of vascular resistance as an indicator for vasoconstriction leading many 
investigators to incorrectly conclude there had been modest vasoconstriction. The effect 
of sympathetic activation under high blood flow conditions is small if expressed using 
vascular resistance but much larger if expressed using vascular conductance (O'Leary, 
1991). Additionally, the changes in vascular function can either be expressed as an 
absolute change or percent change (Donald et al., 1970). However, due to differing 
baseline levels, it is most appropriate to express the magnitude of vasoconstriction as a 
percent change in conductance rather than resistance. It is accepted that doing this will 
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always certainly mirror an expectable reduction in vessel diameter (Buckwalter & 
Clifford, 2001). 
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CONCLUSION 
 
 It is certain that the matching of blood flow to metabolism is a requirement for all 
mammalian tissues to properly function. This concept of matching is even more pertinent 
when examining exercising skeletal muscle cells whose metabolism can change 
drastically depending on the intensity and duration of contraction. It has been identified 
that in order to match the increased metabolism of contracting skeletal muscle, there is 
immediate and a substantial increase in blood flow at the onset of exercise (Corcondilas 
et al., 1964; Naik et al., 1999; Tschakovsky et al., 1996). Currently, there is a large 
amount of convincing evidence that this increase in blood flow is a result of rapid dilation 
of skeletal muscle arterioles (Mihok & Murrant, 2004; Murrant, 2005; VanTeeffelen & 
Segal, 2006). Although it was formerly hypothesized that the autonomic nervous system 
is responsible for this immediate exercise hyperemia, it now appears that the immediate 
vasodilation observed in contracting skeletal muscle does not depend on the autonomic 
nervous system (Buckwalter & Clifford, 1999; Sheriff et al., 1993). As a result, a large 
amount of research has been carried out to investigate different factors that might be at 
work, independent of the nervous system, to ensure proper matching of blood flow to 
metabolism. 
 At first look, it seems paradoxical to accept that the sympathetic nervous system 
constricts blood vessels in active skeletal muscle as well as inactive tissues. However, it 
is important to recognize that this is absolutely necessary in order to maintain systemic 
blood pressure, even though the net effect is essentially reduced vasoconstriction in 
exercising muscles due to the high metabolic demand. Research that has focused on the 
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impact of sympathetic nerve activity in skeletal muscle vasculature during exercise has 
concluded that sympathetic vasoconstriction does in fact take place in exercising muscle 
tissue, there is sympathetic restraint of muscle blood flow for proper matching of blood 
flow to metabolism, and that sympathetic vasoconstriction in skeletal muscle is mediated 
by different mechanisms that may involve both adrenergic receptors as well as non-
adrenergic receptors. 
 The focus of this thesis and its proposed experiment are a reflection of the vast 
amount of data that has pointed to the diminished responsiveness of adrenergic receptors 
when stimulated concurrently with certain vasodilatory stimuli. An emphasis is also 
placed here on the effect of ATP and FMD to demonstrate sympatholysis because this 
would strongly suggest that the endothelium is primarily involved in causing 
sympatholysis. Due to the great amount of inconsistencies in the current literature, the 
proposed study, and further studies that go beyond the general scope of this thesis, is 
warranted for a clearer explanation. Accomplishing this task might aid physiologists in 
understanding not only the mechanisms that occur during exercise but also the 
progression and cause of various physiological abnormalities. 
Perspectives 
 Human studies have yielded compelling evidence that indicates that blood flow to 
both contracting and resting skeletal muscle is controlled in order to maintain appropriate 
oxygen delivery in a variety of different conditions that change blood oxygen content and 
sympathetic nerve activity, such as hypoxia, hyperoxia, heat stress, and dehydration 
(Rosenmeier et al., 2004). It makes sense then that there is significant restraint of 
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sympathetic nerve activity and vasodilation in active muscle tissue in order to prevent a 
dramatic fall in peripheral resistance and thus maintain a proper blood pressure. Again, it 
is important to remember, however, that although there is reduced sympathetic 
vasoconstriction in the vasculature of active muscle tissue, vasoconstriction does indeed 
persist in contracting muscle for proper blood flow regulation (Hearon et al., 2016). 
Additional studies should be implemented to determine the mechanisms and factors that 
are involved in causing this phenomenon. Insight into this will aid in understanding not 
only many exercise-related conditions and their treatments, but also in many types of 
cardiovascular and systemic diseases, some of which are discussed next. 
 An amplified sympathetic nervous system activity and weakened vasodilatory 
capacity during muscular contraction often go hand-in hand with age-related 
cardiovascular diseases (Richards et al., 2014). Thus, hypertensive patients make up one 
population that exhibits impaired functional sympatholysis. One study that directly tested 
this impairment in hypertensive patients found that the hypertensive group showed a 
large decrease in muscle oxygenation and blood flow levels during forearm exercise 
compared to the normotensive group (Vongpatanasin et al., 2011). As is obvious from 
this data, determining the methods by which functional sympatholysis occurs would have 
significant clinical implications for patients with high blood pressure and other similar 
diseases. 
 Exercise intolerance due to impaired functional sympatholysis is also a concern 
for patients with chronic myocardial infarction, or heart failure. One study attempted to 
measure arterial pressure and femoral artery blood flow responses to sympathetic nerve 
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stimulation in resting and contracting rat hindlimb both in normal rats and also rats with 
chronic myocardial infarction (Thomas et al., 2001). Although there was no difference in 
vascular conductance in the two rat groups when the hindlimb was not contracting, the 
normal rat group had a much larger attenuation in sympathetic vasoconstriction than the 
myocardial infarction group when the hindlimb was contracting. Once again, this 
evidence points to the importance of discovering the vascular signaling pathways that are 
responsible for causing sympatholysis, both at rest and during muscular contraction. 
 Lastly, Type II diabetes is a metabolic disorder in which blood glucose levels 
elevate to abnormally high levels due to insulin resistance. One recent study found that 
there was a reduction in vasodilation caused by purines, such as ATP, in type II diabetic 
patients compared to normal individuals (Thaning et al., 2010). Several different potential 
explanations were listed in this study, including there being less ATP released by 
erythrocytes and an increased sympathetic tone leading to impaired functional 
sympatholysis in diabetics. This, therefore, might suggest that endothelial dysfunction in 
type II diabetic patients complicates important cardiovascular functions, such as 
functional sympatholysis.  
In conclusion, the cardiovascular system works through many elaborate 
mechanisms to meet the demands of different organ systems. Importantly, exercise 
depends on some of these mechanisms to make sure that active muscles receive an 
increased blood flow to match their increased metabolism. Functional sympatholysis has 
been coined as the process that is responsible for this crucial matching; however, the 
current research does not indicate a clear mechanism for how it occurs. Even though the 
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endothelium was the main focus here, the consideration of other factors should not be 
avoided. Finally, further research into this topic could also provide information about 
other physiological relevancies, such as cardiovascular and metabolic diseases, and aid in 
interpreting the impaired vascular functions and possible treatment options. 
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